103 related articles for article (PubMed ID: 8356219)
1. Management of Hodgkin's disease patients with mediastinal adenopathy and pulmonary involvement (stage IIE).
Baysogolov GD; Shakhtarina SV; Afanasova NV
Radiother Oncol; 1993 May; 27(2):107-11. PubMed ID: 8356219
[TBL] [Abstract][Full Text] [Related]
2. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.
Hughes-Davies L; Tarbell NJ; Coleman CN; Silver B; Shulman LN; Linggood R; Canellos GP; Mauch PM
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):361-9. PubMed ID: 9308940
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease with direct extension into pulmonary parenchyma from a mediastinal mass: a presentation requiring special therapeutic considerations.
Wiernik PH; Slawson RG
Cancer Treat Rep; 1982 Apr; 66(4):711-6. PubMed ID: 7074641
[TBL] [Abstract][Full Text] [Related]
4. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Hodgkin's disease with lesions of the mediastinal lymph nodes and involvement in pulmonary processes].
Baĭsogolov GD; Afanasova NV; Shakhtarina SV
Med Radiol (Mosk); 1990 May; 35(5):10-3. PubMed ID: 2342405
[No Abstract] [Full Text] [Related]
6. [Treatment of local Hodgkin's disease with massive mediastinal involvement].
Kondrat'eva NE; Demina EA; Nivinskaia MM; Iur'eva TV; Unukova EN; Paches LR; Pirogova NA
Ter Arkh; 2000; 72(8):45-9. PubMed ID: 11019428
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
[TBL] [Abstract][Full Text] [Related]
8. Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients.
Colonna P; Jais JP; Desablens B; Harousseau JL; Brière J; Boasson M; Lemevel A; Casassus P; Le Prisé PY; Guilhot F; Ghandour C; Lejeune F; Andrieu JM
J Clin Oncol; 1996 Jun; 14(6):1928-35. PubMed ID: 8656262
[TBL] [Abstract][Full Text] [Related]
9. Influence of mediastinal adenopathy on site and frequency of relapse in patients with Hodgkin's disease.
Mauch P; Gorshein D; Cunningham J; Hellman S
Cancer Treat Rep; 1982 Apr; 66(4):809-17. PubMed ID: 7074652
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy.
Behar RA; Horning SJ; Hoppe RT
Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):771-6. PubMed ID: 7683016
[TBL] [Abstract][Full Text] [Related]
12. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Hodgkin's disease with bulky mediastinal involvement. Study of 28 cases].
Acín P; Besses C; Pedro C; Monzó S; Sans-Sabrafén J
Rev Clin Esp; 1997 Nov; 197(11):752-6. PubMed ID: 9547194
[TBL] [Abstract][Full Text] [Related]
14. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
15. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
[TBL] [Abstract][Full Text] [Related]
16. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
[TBL] [Abstract][Full Text] [Related]
17. Mediastinal irradiation in combined modality therapy for Hodgkin's disease.
Dowling SW; Peschel RE; Portlock CS; Kramer C; Farber LR; Knowlton AH
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):543-6. PubMed ID: 2211202
[TBL] [Abstract][Full Text] [Related]
18. Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatment.
Zinzani PL; Mazza P; Gherlinzoni F; Bocchia M; Fiacchini M; Bendandi M; Barbieri E; Frezza G; Neri S; Aitini E
Leuk Lymphoma; 1992 Sep; 8(1-2):81-5. PubMed ID: 1493474
[TBL] [Abstract][Full Text] [Related]
19. [Massive skeletal invasion in Hodgkin's disease observed by MRI].
Suzuki K; Tsuboi I; Inoue M; Sakuma A; Takizawa T; Koyama S; Sawada U; Kitami Y
Rinsho Ketsueki; 1994 Feb; 35(2):142-7. PubMed ID: 8139111
[TBL] [Abstract][Full Text] [Related]
20. Treatment of early clinically staged Hodgkin's disease with a combination of ABVD chemotherapy plus limited field radiotherapy.
Karmiris TD; Grigoriou E; Tsantekidou M; Spanou E; Mihalakeas H; Baltadakis J; Apostolidis J; Pagoni M; Karakasis D; Bakiri M; Mitsouli C; Harhalakis N; Nikiforakis E
Leuk Lymphoma; 2003 Sep; 44(9):1523-8. PubMed ID: 14565654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
